Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

AstraZeneca UK Limited
Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 28/02/2011
PIL Betaloc I.V. Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/02/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 05/01/2010 and displayed until 28/02/2011
Reasons for adding or updating:
  • Change of manufacturer
Updated on 09/06/2008 and displayed until 05/01/2010
Reasons for adding or updating:
  • Change to side-effects
  • Change due to user-testing of patient information
Updated on 03/05/2007 and displayed until 09/06/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change from BAN to rINN
Updated on 12/08/2005 and displayed until 03/05/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 04/09/2002 and displayed until 12/08/2005
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  metoprolol tartrate